Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation.
暂无分享,去创建一个
G. Salles | A. Stamatoullas | N. Brousse | C. Sebban | C. Haioun | E. Deconinck | P. Colombat | P. Lederlin | P. Solal-Céligny | N. Milpied | C. Foussard | F. Montestruc | C. Thieblemont | P. Soubeyran | A. Najman | V. Delwail | B. Taillan | A. Mathieu-Boué | P. Eftekhari | A. Benzohra | F. Boué | C. Haïoun | Pitahey Eftekhari | Piere Soubeyran | Astasia Stamatoullas